Premium Information is available for this item - Upgrade for $1 a day
6505-01-363-0935
Leuprolide Acetate Injection Kit
6505013630935 013630935 LUPRON NDC00300-3626-28
January 2023
7
Marketplace 6505-01-363-0935
Request a Quotation from participating marketplace vendors
Related Documents 6505-01-363-0935 5+ Documents (More...)
6505-01-554-4021 https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-363-0935 Leuprolide Acetate
Injection Kit 013630935 KT Subscribe NATO Stock Numbers Related to 6505-01-363-0935 6505-01-554-4022
Leuprolide Acetate Injection Kit 013630935 Upgrade your Account Upgrade 6505-01-363-0935Leuprolide
Acetate Injection Kit6505013630935 013630935 LUPRON Numbers Related to 6505-01-363-0935 6505-01-554-
4022 Leuprolide Acetate Injection Kit 015544022 Related to 6505-01-554-4022 6505-01-554-4022 6505-01-363-0935
Leuprolide Acetate Injection Kit 013630935 Related to 6505-01-363-0935 6505-01-554-4022 6505-01
6505-01-554-4021 6505-01-252-0045 6505-33-190-5323 6505-33-190-5903 310-7326 6505-01-554-4022 6505-01-363-0935
6505/us 6505-01-554-4022 Leuprolide Acetate Injection Kit 015544022 554-4022 6505-01-554-4022 6505-01-363-0935
Leuprolide Acetate Injection Kit 013630935 0935 54Operational Test:No Special Procedures NATO Stock
6505-01-554-4022 1994Veterans Administration (VA)KT Subscribe NATO Stock Numbers Related to 6505-01-363-0935
Restrictions 6505-01-363-0935
6505-01-363-0935 is a Leuprolide Acetate Injection Kit that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. The precious metals content of this item is unknown.
Import and Export 6505-01-363-0935
- Schedule B
- Subscribe to View Schedule B
- HTS Code
- Subscribe to View HTS Code
End Users 6505-01-363-0935
- MOE Rule:
- V542
- Effective Date:
- 1 Jan 1994
Approved Sources 6505-01-363-0935
- Part Number
- Manufacturer
- Status
- LUPRON
- Manufacturer
- 49476 - Tap Pharmaceutical Products Inc (Active)
- Incomplete Reference
- Incomplete Reference
- NDC00300-3626-28
- 49476 - Tap Pharmaceutical Products Inc (Active)
- Primary Buy
- Primary Buy
Datasheet 6505-01-363-0935
- Characteristic
- Specifications
- FIIG
- Specifications
- A505R0
- Protective Storage Feature [AJCN]
- Antineoplastic Drug And Requires Refrigeration Storage Between 2 To 8 Deg Celsius And Subject To Damage By Freezing
- Special Features [FEAT]
- Sterile; Aqueous Solution; 5 Mg. Leuprolide Acetate Per Ml.
- Usage Design [ALCD]
- For Use In The Treatment Of Prostatic Cancer
Management Data 6505-01-363-0935
- Effective Date
- Organization
- Unit of Issue
- Unit Price
- Qty Unit Pack
- Unit of Issue
- Jan 1994
- Veterans Administration (VA)
- KT
- Subscribe
- KT
NATO Stock Numbers Related to 6505-01-363-0935
Freight Information 6505-01-363-0935
6505-01-363-0935 has freight characteristics.. 6505-01-363-0935 has a variance between NMFC and UFC when transported by rail and the description should be consulted.